[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336970-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336970-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tissue-resident-macrophages-in-cancer-friend-or-foe","Tissue-Resident Macrophages in Cancer: Friend or Foe?","","Macrophages are central to homeostasis, infection defense, and disease progression, with tissue-resident macrophages (TRMs) differing from hematopoietic stem cell and circulating monocyte-derived macrophage lineages. A literature-based synthesis summarizes how tumor-associated macrophages (TAMs) accumulate within the tumor microenvironment, including TRM-derived TAMs that closely match normal TRM gene programs. TRMs are shown to drive cancer progression while organ-specific effects and internal heterogeneity complicate their study. The review proposes that understanding TRM roles supports targeted TRM-focused therapies across tumor sites.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tissue-resident-macrophages-in-cancer-friend-or-foe/336970/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tissue-resident-macrophages-in-cancer-friend-or-foe/336970.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes tissue-resident macrophages (TRMs) different from other macrophage sources?","Question",{"text":63,"@type":64},"TRMs differ from hematopoietic stem cell-derived and circulating monocyte-derived macrophages in genetics, development, and function.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do TRMs relate to tumor-associated macrophages (TAMs) in the tumor microenvironment?",{"text":68,"@type":64},"TRMs and circulating monocytes jointly provide the pool of TAMs, and TRM-derived TAMs closely resemble gene signatures of normal TRMs.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is distinguishing TRMs from monocyte-derived TAMs important?",{"text":72,"@type":64},"Because macrophages within TAM populations can originate from different lineages, and the review highlights that TRM functions in cancer remain unclear and may be organ-specific.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336970,1790196311,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Medicine  \nREVIEW  OPEN ACCESS   \nTissue-Resident Macrophages in Cancer: Friend or Foe?  \nJianhua Chi1,2  | Qinglei Gao1,2  | Dan Liu1,2  \n1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College,  \nHuazhong University of Science and Technology, Wuhan, China | 2Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumor Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Correspondence: Qinglei Gao ([qingleigao@hotmail.com](qingleigao@hotmail.com)) | Dan Liu ([tj_liudan@tjh.tjmu.edu.cn](tj_liudan@tjh.tjmu.edu.cn))  \nReceived: 18 July 2024 | Revised: 15 October 2024 | Accepted: 20 October 2024  \nFunding: Research work in this publication was funded by National Science Foundation of China (Grants 82373332 and 81974405), Hubei Natural Science Foundation Outstanding Young Talents Project (Grants 2022CFA051), and the Knowledge Innovation Program of Wuhan-Basic Research (Grants 2023020201010051) .  \nKeywords: cancer immunology | tissue-resident macrophages | tumor microenvironment | tumor-associated macrophages  \nABSTRACT  \nIntroduction: Macrophages are essential in maintaining homeostasis, combating infections, and influencing the process of various diseases, including cancer. Macrophages originate from diverse lineages: Notably, tissue-resident macrophages (TRMs) differ from hematopoietic stem cells and circulating monocyte-derived macrophages based on genetics, development, and function. Therefore, understanding the recruited and TRM populations is crucial for investigating disease processes.  \nMethods: By searching literature databses, we summarized recent relevant studies. Research has shown that tumor-associated macrophages (TAMs) of distinct origins accumulate in tumor microenvironment (TME), with TRM-derived TAMs closely resembling gene signatures of normal TRMs.  \nResults: Recent studies have revealed that TRMs play a crucial role in cancer progression. However, organ-specific effects complicate TRM investigations. Nonetheless, the precise involvement of TRMs in tumors is unclear. This review explores the multifaceted roles ofTRMs in cancer, presenting insights into their origins, proliferation, the latest research methodologies, their impact across various tumor sites, their potential and strategies as therapeutic targets, interactions with other cells within the TME, and the internal heterogeneity ofTRMs.  \nConclusions: We believe that a comprehensive understanding of the multifaceted roles ofTRMs will pave the way for targeted TRM therapies in the treatment of cancer.  \n1 | Introduction  \nMacrophages are innate immune cells found in non-immune organs [1] . Macrophages can polarize and induce diverse functional phenotypes in reaction to external stimuli. Two decades ago, Mills et al. proposed a binary classification of macrophage polarization into M1 and M2 phenotypes [2] . “M1-like”phenotype is typically pro-inflammatory, recognized as associated with anti-tumor macrophages. Conversely, “M2-like”macrophages are characterized as anti-inflammatory and pro-cancer. However, this paradigm has been further refined.  \nStudies have shown that macrophages support tumor growth, angiogenesis, immunosuppression, and metastasis in tumors [3] . Co-expression of both M1 and M2 gene signatures has been identified in macrophage subsets across nearly all cancer types [4–6] . Macrophages can be grouped into subpopulations using new technologies [7]. Tissue-resident macrophages (TRMs) and circulating monocytes provide the pool of tumor-associated macrophages (TAMs) [8] . TRM-derived TAMs closely resemble gene signatures of normal TRMs [9, 10] . Besides, TRM-derived TAMs are distinct from macrophages derived from hematopoietic stem cells (HSCs) or monocytes in terms of genetics,  \nThis is an open access article under the terms of ","cbCaicohE5kQanlE","https://ap.wps.com/l/cbCaicohE5kQanlE","pdf",5134563,16,"English","# Introduction\n## Macrophage polarization and TAM biology\n# Necessity of Distinguishing TRMs and the Latest Research Methods\n## Distinguishing TRMs from monocyte-derived TAMs","[{\"question\":\"What makes tissue-resident macrophages (TRMs) different from other macrophage sources?\",\"answer\":\"TRMs differ from hematopoietic stem cell-derived and circulating monocyte-derived macrophages in genetics, development, and function.\"},{\"question\":\"How do TRMs relate to tumor-associated macrophages (TAMs) in the tumor microenvironment?\",\"answer\":\"TRMs and circulating monocytes jointly provide the pool of TAMs, and TRM-derived TAMs closely resemble gene signatures of normal TRMs.\"},{\"question\":\"Why is distinguishing TRMs from monocyte-derived TAMs important?\",\"answer\":\"Because macrophages within TAM populations can originate from different lineages, and the review highlights that TRM functions in cancer remain unclear and may be organ-specific.\"}]","Tissue-Resident Macrophages in Cancer: Friend or Foe? | PDF",1790017255,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74e57e79b208f870591f7b511e793c3f.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c14b38cad61c2a39eebdf414f4115df0.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1eff28912ca683c16babbf3a416e768f.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d83f4411b1f0d45e966f3198413fb94.webp",980,1287]